Furthermore, mutations in exon 17 of the c-KIT proto-oncogene, where mutations are most commonly seen in human patients with mastocytosis [19,24,25], do not contribute to the aberrant localization of KIT in canine cutaneous MCTs. The gene discussed is KIT; the disease is mastocytosis.